Vousden, Nicola http://orcid.org/0000-0001-5216-8268
,
Lawley, Elodie
Nathan, Hannah L.
Seed, Paul T.
Brown, Adrian
Muchengwa, Tafadzwa
Charantimath, Umesh
Bellad, Mrutyunjaya
Gidiri, Muchabayiwa Francis
Goudar, Shivaprasad
Chappell, Lucy C.
Sandall, Jane
Shennan, Andrew H.
Funding for this research was provided by:
Medical Research Council (GB) joint funding with Department of International Health and Department of Biotechnology India (MR/N006240/1)
Article History
Received: 4 January 2018
Accepted: 9 April 2018
First Online: 27 April 2018
Ethics approval and consent to participate
: Ethical approval has been granted by the Biomedical Sciences, Dentistry, Medicine and Natural & Mathematical Sciences Research Ethics Subcommittee at King’s College London (LRS-14/15–1484). Local ethical approval from each cluster has been granted by:UnorderedList removedInstitutional level consent was sought prior to implementation of the CRADLE intervention. Informed written consent was sought from HCP participating in interviews, focus group discussions and the action logs of clinical practice.
: The CRADLE VSA has been developed by Microlife with academic input from King’s College London and funding from Bill and Melinda Gates. The device is provided at manufacturing cost for this trial and is available to purchase at low cost to all LMIC. King’s College London receive no funds from the sale of devices to LMIC.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.